logo
Listeria outbreak linked to recalled frozen shakes now blamed for 12 deaths

Listeria outbreak linked to recalled frozen shakes now blamed for 12 deaths

CBS News24-02-2025

A listeria outbreak linked to recalled frozen supplemental nutrition shakes has infected 38 people, killing 12, according to an update on Monday from federal and state health officials.
The infections, which ranged across 21 states, have been traced to recalled products manufactured by Prairie Farms Dairy at a facility in Fort Wayne, Indiana. Swabs collected from the plant's processing area tested positive for listeria, with the investigation ongoing, the Food and Drug Administration stated in a new alert.
The following states have reported cases of listeria tied to the recalled shakes: Alabama, California, Colorado, Connecticut, Florida, Illinois, Indiana, Maryland, Michigan, Minnesota, Missouri, North Carolina, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Washington and West Virginia.
The ongoing outbreak includes illnesses dating back to 2018, with total 20 cases occurring this year and in 2024, according to the U.S. Centers for Disease Control and Prevention.
Of the 38 people for whom information is available, 37 have been hospitalized and 12 deaths have been reported as of Monday. The vast majority of those who were infected with listeria reported living in a long-term care facility or being hospitalized before becoming sick, the CDC said.
The death toll linked to the Prairie Farms Dairy shakes is greater than one in 2024 connected to deli meats made by Boar's Head that resulted in 10 deaths and 57 illnesses in what was labeled the worst listeria outbreak since one in 2011 linked to cantaloupe.
Listeria monocytogenes can cause serious, and sometimes fatal, infections in the young, frail or elderly, as well as in people with weakened immune systems. While healthy individuals may suffer from more minor symptoms, including fever, headache, stiffness, nausea, abdominal pain and diarrhea, the infection can cause miscarriages and stillbirths among pregnant women.
Fresno, California-based food maker Lyons Magnus on Feb. 22 recalled four-ounce Lyons ReadyCare and Sysco Imperial Frozen Supplemental Shakes supplied by Prairie Farms and distributed mostly to nursing homes nationwide.
The recalled products had best-by-dates of February 21, 2025, to February 21, 2026, and came in vanilla, chocolate, strawberry or strawberry banana.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASCO25: AI test shown to aid in prostate cancer treatment planning
ASCO25: AI test shown to aid in prostate cancer treatment planning

Yahoo

time31 minutes ago

  • Yahoo

ASCO25: AI test shown to aid in prostate cancer treatment planning

New research has demonstrated that an AI-based test developed by US-based Artera can help identify which men with non-metastatic high-risk prostate cancer are most likely to benefit from being administered abiraterone. Abiraterone (Zytiga) is an androgen deprivation therapy (ADT) used in men with metastatic castration-resistant prostate cancer (mCRPC) that no longer responds to standard hormone therapy. The ArteraAI test assesses prostate needle biopsy images to provide risk stratification and prediction of the benefits of ADT for prostate cancer patients. Researchers from the UK's Institute of Cancer Research (ICR) and University College London (UCL) applied the test to biopsy images from more than 1,000 men who took part in the Stampede trial (NCT00268476), coordinated by the Medical Research Council (MRC) Clinical Trials Unit at UCL and funded by Cancer Research UK. ArteraAI helped identify that 25% of men with high-risk prostate cancer from the Stampede trial who would most likely benefit from receiving abiraterone. For those patients with biomarker-positive tumours, abiraterone cut the risk of death after five years from 17% to 9%. Full details of the study will be shared during a presentation at the American Society of Clinical Oncology (ASCO) 2025 meeting, taking place from 30 May to 3 June in Chicago, Illinois. Nick James, professor of prostate and bladder cancer research at the Institute of Cancer Research and consultant clinical oncologist at the Royal Marsden NHS Foundation Trust, served as chief investigator on the STAMPEDE and is co-leader of the current research. James noted that since abiraterone comes with potential side effects that may require additional monitoring, such as potential issues with high blood pressure and liver abnormalities, knowing who is most likely to benefit is 'very valuable'. He said: 'This research shows that we can pick out the people who will respond best to abiraterone, and those who will do well from standard treatment alone – hormone therapy and radiotherapy.' Abiraterone is indicated for use on the UK National Health Service (NHS) in England for patients with advanced prostate cancer that has come back and spread to other parts of the body, but not for patients newly diagnosed with high-risk prostate cancer that has not yet spread. However, abiraterone has been available for men with this indication in Scotland and Wales for two years. The study's co-lead UCL Cancer Institute professor Gert Attard commented: 'This study shows, in a very large cohort of patients, that novel algorithms can be used to extract information from routinely available pathology slides to tailor these treatments to specific patients and minimise over-treatment while maximising the chance of cure." "ASCO25: AI test shown to aid in prostate cancer treatment planning" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

TMD SPACE Launches New Strategic Partnership to Accelerate Global Expansion for Thai Wellness Brands
TMD SPACE Launches New Strategic Partnership to Accelerate Global Expansion for Thai Wellness Brands

Associated Press

time42 minutes ago

  • Associated Press

TMD SPACE Launches New Strategic Partnership to Accelerate Global Expansion for Thai Wellness Brands

TMD SPACE announces a new strategic partnership aimed at helping Thai wellness brands expand globally through targeted communications, international media outreach, and tailored market-entry strategies. Bangkok, Thailand, May 30, 2025 -- TMD SPACE, a leading strategic communications firm, has launched a new initiative in partnership with Thai wellness brands to support its international growth. The collaboration aims to enhance global visibility and build trust in key markets such as the CLMV bloc, the Middle East, and Europe. With Thailand strengthening its reputation as a global wellness destination, local wellness businesses are increasingly exploring cross-border opportunities. TMD SPACE's latest partnership reflects this momentum, supporting Thai wellness brands in reaching international consumers and business partners through expert communication strategies. TMD SPACE Launches New Strategic Partnership to Accelerate Global Expansion for Thai Wellness Brands Under this collaboration, TMD SPACE will provide comprehensive strategic support—from media outreach and brand storytelling to market-specific messaging and digital visibility. The goal is to help Thai wellness brands cultivate international credibility and drive sustainable growth. 'This partnership is about more than promotion—it's about building long-term global recognition,' said Nawaphon Hinsui, Founder and CEO of TMD SPACE. 'Success in international markets depends on delivering the right message to the right audience. We're here to ensure Thai wellness brands are not only seen, but trusted and valued globally.' The initiative comes amid rising global demand for wellness products and services rooted in holistic, culturally rich practices. TMD SPACE's strategic approach positions Thai brands to seize this opportunity with clarity, confidence, and measurable impact. The partnership is already in motion, with initial campaigns targeting Southeast Asia and the Middle East. TMD SPACE welcomes inquiries from other wellness businesses looking to explore global expansion through strategic communications. About TMD SPACE Co., Ltd. TMD SPACE is a Bangkok-based strategic communications agency with over a decade of experience in public relations, digital marketing, and international media relations. Their integrated solutions include media outreach, content creation, performance marketing, SEO/SEM, analytics, and campaign strategy. With access to 300+ global media outlets and platforms, TMD SPACE helps Thai brands build visibility, credibility, and sustainable growth worldwide. Media Contact: TMD SPACE Co., Ltd. Email: [email protected] Tel: +66 2 679 3585 Website: Contact Info: Name: Nawaphon Email: Send Email Organization: TMD SPACE Website: Release ID: 89160816 Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.

Mobile Anesthesia Now Expanding Availability for Dental Offices in the Portland Metro Area
Mobile Anesthesia Now Expanding Availability for Dental Offices in the Portland Metro Area

Associated Press

time42 minutes ago

  • Associated Press

Mobile Anesthesia Now Expanding Availability for Dental Offices in the Portland Metro Area

Oregon-based Nightlight Anesthesia has announced mobile service availability for Portland-area dental offices SHERWOOD, OREGON - MAY 29, 2025 - Oregon-based Nightlight Anesthesia has officially announced that it will now be expanding availability of it's mobile services for dental offices in the Portland Metro area. Now, Portland Metro dental offices can take advantage of this convenient service to ensure the height of patient satisfaction, comfort, and safety. Nightlight Anesthesia brings anesthesia services to medical and dental offices and surgery centers. The company's team brings everything needed to provide quality anesthesia, including equipment, medications, and talented experts who are committed to providing the best in care. 'Whatever the needs of your facility, we make the process of providing anesthesia care for your patients smooth and stress free,' said the team at Nightlight Anesthesia. The team at Nightlight Anesthesia includes trained and expert CRNAs with decades of combined experience. Founders Brad Johnson, MN, CRNA, and Josh Dillard, MN, CRNA, are committed to providing exceptional client services and have demonstrated that through years of service. By offering mobile services, Nightlight Anesthesia makes it easy for facilities to provide world-class anesthesia for their patients. In fact, Nightlight Anesthesia has been the recipient of a long list of five-star reviews from clients. One recent client said, 'Brad and Josh have allowed me to implement anesthesia services into my dental practice with ease. They are professional, great communicators with our team, provide exceptional treatment for our patients, and are enjoyable to work with.' Nightlight Anesthesia truly helps facilities provide the best care for their patients and even offers patient papers including pre-anesthesia instructions, aftercare directions, and pediatric aftercare directions. Clients can simply scan a QR code at the Nightlight Anesthesia website to access the pre-anesthesia forms. At every step of the way, this locally owned and operated company is ensuring quality mobile anesthesia solutions for facilities across Oregon. Now, dental offices in the Portland Metro area are being serviced by Nightlight Anesthesia. This opens up a new option for trustworthy, expert anesthesia services for dentists in the surrounding areas. 'We are committed to supporting local dentists, their staff, and their patients with quality mobile anesthesia,' said Nightlight Anesthesia. Local dentists who are interested in partnering with a mobile anesthesia provider are welcome to connect with Nightlight Anesthesia to learn more. Further details, including how to contact the company, can be found at ABOUT NIGHTLIGHT ANESTHESIA Nightlight Anesthesia offers mobile anesthesia services for Oregon medical and dental offices and surgery centers. Media Contact Company Name: Nightlight Anesthesia Contact Person: Josh Dillard Email: Send Email Country: United States Website: Source: Oregon Web Solutions

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store